FindTrial
Sign In

The value of adjuvant therapy of potassium iodide in patients with hyperthyroidism RAI but not cured after treatment

The value of adjuvant therapy of potassium iodide in patients with hyperthyroidism RAI but not cured after treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086834
Enrollment
Unknown
Registered
2024-07-11
Start date
2018-10-09
Completion date
Unknown
Last updated
2024-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperthyroidism

Interventions

experimental group:Adjunctive potassium iodide
control group:none

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 73 Years

Inclusion criteria

Inclusion criteria: 1) Patients diagnosed with GD who, six months after RAI treatment, showed significant improvement after treatment but did not recover and subclinical hyperthyroidism. 2) Age 18-70 years old, gender is not limited. 3) Normal blood routine, liver and kidney function. 4) Participate voluntarily and sign informed consent.

Exclusion criteria

Exclusion criteria: 1) Patients with active tuberculosis. 2) People who are allergic to iodide 3) Patients with acute bronchitis, pulmonary edema and hyperkalemia. 4) Pregnant women. 5) Patients who are unable to cooperate with treatment.

Design outcomes

Primary

MeasureTime frame
serum FT3 and FT4;—

Countries

China

Contacts

Public ContactXingmin Han

The First Affiliated Hospital of Zhengzhou University

xmhan@zzu.edu.cn+86 138 3817 8090

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026